688046 药康生物
2026/09 - 九个月
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资82,397-7.22%88,81280,04369,19868,536
投资性房地产0--0000
固定资产563,410-1.72%573,247493,222486,699194,079
在建工程32,41244.30%22,46190,85289,603171,670
无形资产66,987-6.14%71,37249,04647,34148,514
商誉0--0000
其他非流动资产366,4702.45%357,702149,709227,226303,907
1,111,676-0.17%1,113,593862,871920,067786,706

流动资产
货币资金385,163-20.85%486,621701,372560,166421,708
应收账款424,79610.35%384,962350,806269,390185,216
存货104,04742.61%72,96154,19747,09249,471
其他流动资产880,2409.09%806,930603,399780,875810,616
1,794,2462.44%1,751,4741,709,7741,657,5231,467,010

流动负债
短期借款116,215-37.96%187,32588,04076,15712,206
应付票据0--0000
应付帐款75,65211.03%68,13472,175101,86050,787
其他流动负债286,4615.44%271,685210,980188,392151,077
478,329-9.26%527,144371,196366,409214,070
流动资产净值1,315,9177.48%1,224,3301,338,5781,291,1141,252,940
资产总额减流动负债2,427,5943.84%2,337,9232,201,4502,211,1812,039,647

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债99,319-10.30%110,72666,72386,52461,933
99,319-10.30%110,72666,72386,52461,933

总权益
    实收股本410,1860.05%410,000410,000410,000410,000
    储备项目1,918,0885.55%1,817,1971,724,7261,714,6561,567,714
股东权益2,328,2744.54%2,227,1972,134,7262,124,6561,977,714
非控股权益0--0000